Cerity Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
206,279
+35,892
| +21% | +$33.9K | ﹤0.01% | 2363 |
|
|
2025
Q1 | $78.5K | Buy |
170,387
+73,875
| +77% | +$34K | ﹤0.01% | 2348 |
|
|
2024
Q4 | $71.3K | Buy |
96,512
+74,000
| +329% | +$54.7K | ﹤0.01% | 2364 |
|
|
2024
Q3 | $35.3K | Hold |
22,512
| – | – | ﹤0.01% | 2498 |
|
|
2024
Q2 | $37.8K | Hold |
22,512
| – | – | ﹤0.01% | 2183 |
|
|
2024
Q1 | $54K | Buy |
+22,512
| New | +$54K | ﹤0.01% | 2244 |
|
|
2022
Q1 | – | Sell |
-73,000
| Closed | -$288K | – | 1039 |
|
|
2021
Q4 | $288K | Buy |
+73,000
| New | +$288K | ﹤0.01% | 782 |
|